Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 5521 AL 5535

Reply to: "Moving Forward in Movement Disorders: The Need for Studies on Environmental Triggers"

Harder-Rauschenberger L, Ip CW.

Mov Disord. 2026 Feb;41(2):553-554. doi: 10.1002/mds.70172. Epub 2025 Dec 29.

Moving Toes Syndrome in Children and Youth: Case Series of a Rare Disorder

Doja A, Tripathi R, Scarisbrick D, Kimble W, Soliani L, Pugliano R, Cordelli DM, Bergonzini L.

J Child Neurol. 2026 May;41(5):743-746. doi: 10.1177/08830738251383179. Epub 2025 Oct 21.

Minimizing Botulinum Toxin Wastage: Insights From a Movement Disorders Practice

Hameed S, Shah B, Higinbotham A, Dalrymple WA, Figari-Jordan R.

Mov Disord Clin Pract. 2026 Mar;13(3):841-842. doi: 10.1002/mdc3.70421. Epub 2025 Oct 31.

Transforming Pediatric Movement Disorders Assessment: From Expert Consensus to Collaborative Approaches

Gimeno H, Desjardins C, Nilles C, Peall KJ, Martino D, Pringsheim T, Roze E.

Mov Disord. 2026 Jan;41(1):286-287. doi: 10.1002/mds.70163. Epub 2025 Dec 22.

Polysomnography and Autonomic Function Signatures of Nocturnal Enuresis: An Observational Study

Thosare P, Chakrabarty B, Gulati S, Jariyal A, Hari P, Jauhari P, Kabra S, Sikka K, Pandey RM, Dutt Upadhyay A, Khan S.

Pediatr Neurol. 2026 Feb;175:102-107. doi: 10.1016/j.pediatrneurol.2025.11.003. Epub 2025 Nov 8.

Deep brain stimulation in patients with mixed movement disorders linked to ADCY5

Retailleau E, Dorison N, Poulen G, Roubertie A, Trouillard O, Baik J, Conabady E, François-Heude MC, Chauvet-Piat E, Spitz MA, Ravelli C, Vayssière P, Nilles C, Desjardins C, Dubacq C, Roze E.

Rev Neurol (Paris). 2026 Mar;182(3):113-119. doi: 10.1016/j.neurol.2025.12.003. Epub 2025 Dec 26.

A Comparative Study of Polysomnography-Derived Sleep Disturbance in People Living With Multiple Sclerosis Compared to Matched Controls From the General Population

Reynolds AC, Thomas E, Melaku YA, Hensen HA, Krishnan AV, Gandevia SC, Lord SR, Eastwood PR, Eckert DJ.

J Sleep Res. 2026 Feb;35(1):e70075. doi: 10.1111/jsr.70075. Epub 2025 Apr 28.

Movement disorders rounds: Neurophysiological findings in abdominal movements in CASPR2 encephalitis

Grippe T, Abkur T, Lin YY, Shafa G, Rastogi A, Chen R, Kalia LV.

Parkinsonism Relat Disord. 2026 Jan;142:107998. doi: 10.1016/j.parkreldis.2025.107998. Epub 2025 Aug 19.

Immature ovarian teratomas in anti-NMDA receptor encephalitis

Simone K, Nathoo N, Hooper A, Aboseif A, Buletko AB, Satkunam N, McCombe JA, Pin S.

J Neuroimmunol. 2026 Mar;412:578850. doi: 10.1016/j.jneuroim.2025.578850. Epub 2025 Dec 26.

A review of treatment methods for movement disorders

Khezri M, Afsar S.

Behav Brain Res. 2026 Mar 5;500:115979. doi: 10.1016/j.bbr.2025.115979. Epub 2025 Dec 4.

Clinical neurophysiology in movement disorders: toward integration into systems-based practice

Lizarraga KJ, Chen R.

Clin Neurophysiol. 2026 Mar;183:2111480. doi: 10.1016/j.clinph.2025.2111480. Epub 2025 Dec 16.

The Influence of Videography in the Foundation and Future of Movement Disorders

Rosso M, Chu D, Barton B.

Mov Disord Clin Pract. 2026 Feb;13(2):359-368. doi: 10.1002/mdc3.70299. Epub 2025 Aug 26.

Nanotechnology in Parkinson's Disease: overcoming drug delivery challenges and enhancing therapeutic outcomes

Ali I, Adil M, Imran M, Qureshi SA, Qureshi S, Hasan N, Ahmad FJ.

Drug Deliv Transl Res. 2026 Mar;16(3):855-893. doi: 10.1007/s13346-025-01799-8. Epub 2025 Jan 29.

Effects of LSVT LOUD and EMST in individuals with Parkinson's disease: A two arm non-randomized clinical trial

Saleem S, Miles A, Allen J.

Int J Speech Lang Pathol. 2026 Feb;28(1):140-154. doi: 10.1080/17549507.2025.2455635. Epub 2025 Feb 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias